JP2006516140A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516140A5 JP2006516140A5 JP2004563641A JP2004563641A JP2006516140A5 JP 2006516140 A5 JP2006516140 A5 JP 2006516140A5 JP 2004563641 A JP2004563641 A JP 2004563641A JP 2004563641 A JP2004563641 A JP 2004563641A JP 2006516140 A5 JP2006516140 A5 JP 2006516140A5
- Authority
- JP
- Japan
- Prior art keywords
- tested
- compounds
- found
- examples
- above assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43510202P | 2002-12-20 | 2002-12-20 | |
| PCT/US2003/040126 WO2004058148A2 (en) | 2002-12-20 | 2003-12-16 | Mitotic kinesin inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006516140A JP2006516140A (ja) | 2006-06-22 |
| JP2006516140A5 true JP2006516140A5 (enExample) | 2010-07-15 |
Family
ID=32682157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004563641A Ceased JP2006516140A (ja) | 2002-12-20 | 2003-12-16 | 有糸分裂キネシン阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7622468B2 (enExample) |
| EP (1) | EP1581497A4 (enExample) |
| JP (1) | JP2006516140A (enExample) |
| AU (1) | AU2003297230B2 (enExample) |
| CA (1) | CA2509212A1 (enExample) |
| WO (1) | WO2004058148A2 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004058700A2 (en) * | 2002-12-20 | 2004-07-15 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| JP2007515945A (ja) * | 2003-05-30 | 2007-06-21 | ロゼッタ インファーマティックス エルエルシー | キネシン活性の調節因子を同定するための方法 |
| ATE550019T1 (de) | 2005-05-17 | 2012-04-15 | Merck Sharp & Dohme | Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| BRPI0806245B1 (pt) | 2007-01-10 | 2022-01-25 | Msd Italia S.R.L. | Compostos de fórmula i e seus usos |
| WO2009052288A1 (en) | 2007-10-19 | 2009-04-23 | Schering Corporation | Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting ksp kinesin activity |
| EP2413932A4 (en) | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | HAMMER OF ACT ACTIVITY |
| CA2777043C (en) | 2009-10-14 | 2015-12-15 | Schering Corporation | Substituted piperidines that increase p53 activity and the uses thereof |
| EP2584903B1 (en) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
| CN103068980B (zh) | 2010-08-02 | 2017-04-05 | 瑟纳治疗公司 | 使用短干扰核酸（siNA）的RNA干扰介导的联蛋白（钙粘蛋白关联蛋白质），β1（CTNNB1）基因表达的抑制 |
| RU2745848C2 (ru) | 2010-08-17 | 2021-04-01 | Сирна Терапьютикс, Инк. | ОПОСРЕДУЕМОЕ РНК-ИНТЕРФЕРЕНЦИЕЙ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ ГЕНОВ ВИРУСА ГЕПАТИТА B (HBV) С ПРИМЕНЕНИЕМ МАЛОЙ ИНТЕРФЕРИРУЮЩЕЙ НУКЛЕИНОВОЙ КИСЛОТЫ (миНК) |
| EP2613782B1 (en) | 2010-09-01 | 2016-11-02 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
| WO2012058210A1 (en) | 2010-10-29 | 2012-05-03 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA) |
| WO2012087772A1 (en) | 2010-12-21 | 2012-06-28 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
| EP2770987B1 (en) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| EP3919620A1 (en) | 2012-05-02 | 2021-12-08 | Sirna Therapeutics, Inc. | Short interfering nucleic acid (sina) compositions |
| CA2882950A1 (en) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| CN103804283B (zh) * | 2012-11-06 | 2016-04-20 | 中国科学院大连化学物理研究所 | 一种制备1,2-二氢吡啶衍生物的方法 |
| SMT201700595T1 (it) | 2012-11-28 | 2018-03-08 | Merck Sharp & Dohme | Composizioni e metodi per trattare il cancro |
| WO2014100065A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
| WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
| WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| CN104756984B (zh) * | 2015-03-30 | 2016-08-17 | 上海应用技术学院 | 多取代顺式二苯乙烯类化合物作为农用杀菌剂的应用 |
| JOP20190055A1 (ar) | 2016-09-26 | 2019-03-24 | Merck Sharp & Dohme | أجسام مضادة ضد cd27 |
| US10975084B2 (en) | 2016-10-12 | 2021-04-13 | Merck Sharp & Dohme Corp. | KDM5 inhibitors |
| JP7160833B2 (ja) | 2017-04-13 | 2022-10-25 | サイロパ ビー．ブイ． | 抗ｓｉｒｐアルファ抗体 |
| WO2019094312A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| EP3706742B1 (en) | 2017-11-08 | 2023-03-15 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| WO2019148412A1 (en) | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1/lag3 bispecific antibodies |
| WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| WO2020033285A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| CA3108388A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| EP3833667B1 (en) | 2018-08-07 | 2024-03-13 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| ES3074517T3 (en) | 2019-12-17 | 2026-07-21 | Merck Sharp & Dohme Llc | 4-(3,4-dihydroisoquinolin-2(1h)-yl)-3-hydroxypiperidine derivatives as prmt5 inhibitors for the treatment of cancer and sickle cell disease |
| EP4076459B1 (en) | 2019-12-17 | 2026-04-29 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| EP4076460B1 (en) | 2019-12-17 | 2026-01-21 | Merck Sharp & Dohme LLC | 1,4-dihydro-2h-spiro[isoquinoline-3,4'-piperidine derivatives as prmt5 inhibitors for the treatment of cancer |
| ES3022307T3 (en) | 2019-12-17 | 2025-05-28 | Merck Sharp & Dohme Llc | Prmt5 inhibitors |
| DE212025000115U1 (de) | 2024-07-30 | 2026-06-18 | Sairopa B.V. | Anti-SIRP Alpha-Antikörperformulierungen und ihre Verwendung |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| EP0322034A3 (en) * | 1987-12-22 | 1991-01-02 | Merck Sharp & Dohme Ltd. | Methyl tetrahydropyridyl oxadiazoles |
| FR2662442A1 (fr) * | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
| EP0459568A3 (en) * | 1990-05-31 | 1992-09-30 | Merck Sharp & Dohme Ltd. | Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use |
| JP2000119250A (ja) * | 1998-08-11 | 2000-04-25 | Takeda Chem Ind Ltd | 環状アミド化合物、その製造法、中間体及び除草剤 |
| IL165624A0 (en) * | 2002-06-14 | 2006-01-15 | Merck & Co Inc | Mitotic kinesin inhibitors |
| US7235580B2 (en) * | 2002-10-18 | 2007-06-26 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| WO2004058700A2 (en) * | 2002-12-20 | 2004-07-15 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
-
2003
- 2003-12-16 WO PCT/US2003/040126 patent/WO2004058148A2/en not_active Ceased
- 2003-12-16 US US10/539,531 patent/US7622468B2/en not_active Expired - Fee Related
- 2003-12-16 CA CA002509212A patent/CA2509212A1/en not_active Abandoned
- 2003-12-16 EP EP03814073A patent/EP1581497A4/en not_active Withdrawn
- 2003-12-16 AU AU2003297230A patent/AU2003297230B2/en not_active Ceased
- 2003-12-16 JP JP2004563641A patent/JP2006516140A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2024006I1 (el) | Διαμινοπυριμιδινες ως ρ2χ3 και ρ2χ2/3 ανταγωνιστες | |
| CY2019029I1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
| CY2018010I2 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| JP2004502858A5 (enExample) | ||
| EP1693005A4 (en) | ULTRASONIC UNIT AND ULTRASOUND SURVEY | |
| IL229509A0 (en) | Preparations containing chemically modified small molecules and processes using them | |
| PL3718564T3 (pl) | Nowe przeciwciała anty-IL 13 i ich zastosowania | |
| EP1762234A4 (en) | AMPK AKTIVATOR | |
| FI20010926A7 (fi) | Laitteen piilottaminen | |
| NO20030514L (no) | Kommersiell motor i bakgrunnen | |
| ITMI20031127A0 (it) | Anticorpi anti-hgf e loro uso | |
| AU2003900878A0 (en) | Improved sodar sounding in the lower atmosphere | |
| EP2302383A3 (en) | Docetaxel conjugates and immunogens for use in an immunoassay | |
| NO20013352L (no) | Anordning for sortering av marine organismer | |
| IL172510A0 (en) | Antibodies and uses thereof | |
| EP1958792A4 (en) | LIGHT-EMITTING WRITING DEVICE AND THIS INSERTING LIGHT-EMITTING DISPLAY | |
| DE502004001120D1 (de) | Sensorbauteil und nutzen zu seiner herstellung | |
| EP1682088A4 (en) | ORAL MICROEMULSION COMPOSITION WITH BIPHENYLDIMETHYLDICARBOXYLATE AND SILYBIN | |
| EP1609479A4 (en) | Tumorigenesis INHIBITOR | |
| FR2842529B1 (fr) | Composition coextrudable avec le pvdf | |
| RU2004132147A (ru) | Адаптоген | |
| FR2852021B1 (fr) | Methodes et outils pour le criblage d'arn actifs in cellulo | |
| JP2004119933A5 (enExample) | ||
| ITMO20040195A1 (it) | 'kit per la raccolta e la collezione di figurine'. | |
| IL157586A0 (en) | Diagnostic compositions containing an antibody to a beta-arrestin, methods utilizing the same and kits containing the same |